title,time_published,url,ticker,relevance_score,ticker_sentiment_label,ticker_sentiment_score
Stocks That Hit 52-Week Lows On Friday,20220506T160650,https://www.benzinga.com/markets/options/22/05/27050916/52-weeks-high-and-low-article,ADCT,0.005467,Somewhat-Bearish,-0.316405
Stocks That Hit 52-Week Lows On Thursday,20220428T193101,https://www.benzinga.com/markets/options/22/04/26872967/52-weeks-high-and-low-article,ADCT,0.00644,Neutral,0.00032
"The Daily Biotech Pulse: Pfizer Inks Pact With Africa For COVID-19 Pills, Emergent Bio & Ridgeback To Increase Access To Ebola Treatment, ADC Therapeutics & Sobi In European Pact For Lymphoma Drug",20220708T121902,https://www.benzinga.com/general/biotech/22/07/27998206/the-daily-biotech-pulse-pfizer-inks-pact-with-africa-for-covid-19-pills-emergent-bio-ridgeback-to,ADCT,0.189471,Neutral,0.002725
"ADCT Awaits Cami Trial Data, CSTL Boosts Revenue Outlook, ANNX To Report HD Trial Data In Q2",20220510T094515,https://markets.businessinsider.com/news/stocks/adct-awaits-cami-trial-data-cstl-boosts-revenue-outlook-annx-to-report-hd-trial-data-in-q2-1031440845,ADCT,0.098041,Neutral,0.010487
Why Embark Technology Jumped Around 85%; Here Are 108 Biggest Movers From Friday,20220815T074324,https://www.benzinga.com/news/22/08/28488766/why-embark-technology-jumped-around-85-here-are-108-biggest-movers-from-friday,ADCT,0.050894,Neutral,-0.005002
Stocks That Hit 52-Week Lows On Tuesday,20220426T174457,https://www.benzinga.com/markets/options/22/04/26818122/52-weeks-high-and-low-article,ADCT,0.00928,Neutral,-0.009378
Stocks That Hit 52-Week Lows On Tuesday,20220517T153602,https://www.benzinga.com/markets/options/22/05/27256852/52-weeks-high-and-low-article,ADCT,0.041198,Neutral,-0.002735
Stocks That Hit 52-Week Lows On Wednesday,20220427T184104,https://www.benzinga.com/markets/options/22/04/26844275/52-weeks-high-and-low-article,ADCT,0.006956,Neutral,0.003924
Tagworks Pharmaceuticals Announces $65 Million in Series A Financing to Advance Click-to-Release Therapeutics,20230622T135300,https://www.prnewswire.com/apac/news-releases/tagworks-pharmaceuticals-announces-65-million-in-series-a-financing-to-advance-click-to-release-therapeutics-301858150.html,ADCT,0.053449,Neutral,0.0
90 Biggest Movers From Yesterday,20220510T091132,https://www.benzinga.com/news/22/05/27100105/90-biggest-movers-from-yesterday,ADCT,0.050306,Neutral,0.004668
90 Biggest Movers From Yesterday,20220510T091132,https://markets.businessinsider.com/news/stocks/90-biggest-movers-from-yesterday-1031440764,ADCT,0.023017,Neutral,0.003321
"ADC Therapeutics SA  ( ADCT )  Reports Q2 Loss, Lags Revenue Estimates",20240806T124007,https://www.zacks.com/stock/news/2316762/adc-therapeutics-sa-adct-reports-q2-loss-lags-revenue-estimates,ADCT,0.401331,Neutral,0.10645
ABL Bio Taps into Synaffix ADC Technology to Accelerate Development of Bispecific ADC Products - Lonza Group  ( OTC:LZAGY ) ,20230913T070000,https://www.benzinga.com/pressreleases/23/09/n34521672/abl-bio-taps-into-synaffix-adc-technology-to-accelerate-development-of-bispecific-adc-products,ADCT,0.040484,Neutral,0.084387
Bispecific Antibody Clinical Trial Pipeline Appears Robust With 250+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight,20230703T210100,https://www.prnewswire.com/news-releases/bispecific-antibody-clinical-trial-pipeline-appears-robust-with-250-key-pharma-companies-actively-working-in-the-therapeutics-segment--delveinsight-301868673.html,ADCT,0.040795,Neutral,0.06675
Antibody-drug Conjugates Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 180+ Companies Working in the Domain,20230626T210100,https://www.prnewswire.com/news-releases/antibody-drug-conjugates-clinical-trial-pipeline-experiences-momentum-delveinsight-estimates-a-diverse-pipeline-comprising-180-companies-working-in-the-domain-301862784.html,ADCT,0.266604,Neutral,0.085501
Synaffix Announces Expansion of ADC Collaboration with MacroGenics,20230314T121400,https://www.prnewswire.com/news-releases/synaffix-announces-expansion-of-adc-collaboration-with-macrogenics-301771459.html,ADCT,0.054732,Neutral,0.101808
"Chong Kun Dang Pharm Licenses Synaffix ADC Technology, Adds Novel ADC Candidate to Oncology Pipeline",20230206T080000,https://www.prnewswire.com/news-releases/chong-kun-dang-pharm-licenses-synaffix-adc-technology-adds-novel-adc-candidate-to-oncology-pipeline-301738575.html,ADCT,0.049526,Neutral,0.111163
Synaffix Enters License Agreement with Amgen to Build Next Generation ADCs,20230105T140000,https://www.prnewswire.com/news-releases/synaffix-enters-license-agreement-with-amgen-to-build-next-generation-adcs-301714411.html,ADCT,0.059636,Somewhat-Bullish,0.190027
Hummingbird Bioscience and Synaffix Enter License Agreement to Develop a Next Generation Antibody Drug Conjugate  ( ADC )  Program,20230104T191500,https://www.benzinga.com/pressreleases/23/01/n30280537/hummingbird-bioscience-and-synaffix-enter-license-agreement-to-develop-a-next-generation-antibody-,ADCT,0.044469,Neutral,0.110091
Another Award for Synaffix: 'Business Development Team of Year' at the Scrip Awards,20221213T080000,https://www.prnewswire.com/news-releases/another-award-for-synaffix--business-development-team-of-year-at-the-scrip-awards-301700641.html,ADCT,0.051551,Neutral,0.11147
"Stocks That Hit 52-Week Lows On Tuesday - SoundHound AI  ( NASDAQ:SOUN ) , Sonnet BioTherapeutics  ( NASDAQ:SONN ) ",20221122T154845,https://www.benzinga.com/news/22/11/29825126/stocks-that-hit-52-week-lows-on-tuesday,ADCT,0.028072,Neutral,-0.107471
"Intapp, ServiceNow And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Intapp  ( NASDAQ:INTA ) ",20240708T122250,https://www.benzinga.com/news/24/07/39664841/intapp-servicenow-and-other-big-stocks-moving-lower-in-mondays-pre-market-session,ADCT,0.275867,Neutral,-0.054423
"Why Core Scientific Shares Are Trading Lower By Around 32%; Here Are 26 Stocks Moving Premarket - Alset  ( NASDAQ:AEI ) , ADC Therapeutics  ( NYSE:ADCT ) ",20221221T110213,https://www.benzinga.com/news/22/12/30157281/why-core-scientific-shares-are-trading-lower-by-around-32-here-are-26-stocks-moving-premarket,ADCT,0.169279,Somewhat-Bullish,0.218048
40 Stocks Moving In Monday's Mid-Day Session,20220509T160653,https://www.benzinga.com/news/22/05/27082744/40-stocks-moving-in-mondays-mid-day-session,ADCT,0.108173,Neutral,0.004129
"Earnings Scheduled For May 9, 2022",20220509T085247,https://www.benzinga.com/news/earnings/22/05/27068359/earnings-scheduled-for-may-9-2022,ADCT,0.019128,Neutral,-0.097547
Medical Second Opinion Global Market to Register Stunning Growth at a CAGR of ~17% by 2028 | DelveInsight,20230821T210100,https://www.prnewswire.com/news-releases/medical-second-opinion-global-market-to-register-stunning-growth-at-a-cagr-of-17-by-2028--delveinsight-301905294.html,ADCT,0.024347,Neutral,-0.03954
ADC Therapeutics  ( ADCT )  Rises 43% in a Month: Here's Why,20240119T180500,https://www.zacks.com/stock/news/2213007/adc-therapeutics-adct-rises-43-in-a-month-heres-why,ADCT,0.523044,Somewhat-Bullish,0.26941
Is ADC Therapeutics  ( ADCT )  Outperforming Other Medical Stocks This Year?,20240119T144003,https://www.zacks.com/stock/news/2212816/is-adc-therapeutics-adct-outperforming-other-medical-stocks-this-year,ADCT,0.757528,Bullish,0.35605
CytomX Therapeutics Presents Overview of Conditionally-Activated Antibody-Drug Conjugate  ( ADC )  Programs Including Next Generation EpCAM-Targeting CX-2051,20220907T220500,https://www.globenewswire.com/news-release/2022/09/07/2512047/37704/en/CytomX-Therapeutics-Presents-Overview-of-Conditionally-Activated-Antibody-Drug-Conjugate-ADC-Programs-Including-Next-Generation-EpCAM-Targeting-CX-2051.html,ADCT,0.029728,Neutral,0.143088
"Acute Lymphocytic Leukemia Market to Accelerate Substantially by 2032, Assesses DelveInsight | Key Companies in the Market - Beam, Pfizer, Genentech, AbbVie, Fate, Roche, Ascentage, Janssen, Jazz, ADC, Kymera, Syndax, ImmunoGen",20230913T210100,https://www.prnewswire.com/news-releases/acute-lymphocytic-leukemia-market-to-accelerate-substantially-by-2032-assesses-delveinsight--key-companies-in-the-market---beam-pfizer-genentech-abbvie-fate-roche-ascentage-janssen-jazz-adc-kymera-syndax-immunogen-301925772.html,ADCT,0.043778,Neutral,0.052326
"Dollar Tree Reports Weak Earnings, Joins Tesla, Arcos Dorados And Other Big Stocks Moving Lower On Wednesday - Tesla  ( NASDAQ:TSLA ) , Dollar Tree  ( NASDAQ:DLTR ) ",20240313T142200,https://www.benzinga.com/news/24/03/37662379/dollar-tree-reports-weak-earnings-joins-tesla-arcos-dorados-and-other-big-stocks-moving-lower-on-wed,ADCT,0.244109,Bearish,-0.47218
